TSXV/ASG (TSXV/ASG)

TSX Venture Exchange: TSXV/ASG · CAD

CA$0.12

+0.00 (0.0%)· Recorded snapshot

Market cap	9.4M
Revenue (ttm)	24.9M
Net income (ttm)	-1.7M
EPS (ttm)	-CA$0.02
Shares out	78.1M
Volume	0
Beta	-0.55

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 24.9M
Net income (ttm): -1.7M
EPS (ttm): -CA$0.02
Market cap: 9.4M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-36

P25 n/aP50 n/aP75 n/a

ROIC-9.1

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All TSXV/ASG indicators

Market & fundamental data

Available fields

182

Groups with data

Currency

USD

Showing 182 of 182 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CAD
Country	Canada
Country code	CA
Earnings date	2026-11-16
Enterprise value	CAD 13.8M
Exchange	TSX Venture Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	2013
Industry	Medical Devices
Is primary listing	Yes
ISIN number	CA05206X1087
Last earnings date	2026-04-29
Last refreshed	2026-10-28
Market cap	CAD 9.4M
Next earnings date	2026-11-16
Price	CAD 0.12
Price currency	CAD
Sector	Healthcare
SIC code	3841
Stock price date	2026-10-27
Symbol	tsxv/ASG
Website	https://www.aurora-spine.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-18.51%
EV/FCF	54.27x
EV/Sales	0.55x
FCF / EV yield	1.84%
FCF yield	2.71%
P/(FCF - SBC) ratio	77.03x
P/(OCF - SBC) ratio	12.26x
P/B ratio	2.34x
P/FCF ratio	36.84x
P/OCF ratio	10.44x
P/S ratio	0.38x
Price / tangible book value	2.94x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-5.77%
EBITDA margin	-1.92%
FCF margin	1.03%
Gross margin	61.61%
Operating margin	-5.77%
Pretax margin	-6.95%
Profit margin	-6.95%
ROA	-6.17%
ROA (5Y)	-8.17%
ROCE	-16.9%
ROE	-36.03%
ROE (5Y)	-31.43%
ROIC	-9.11%
SBC / revenue	0.53%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	2
FCF growth	-73.31%
Gross profit growth	-1.39%
Gross profit growth (Q)	-21.46%
Gross profit growth 3Y	13.85%
Gross profit growth 5Y	21.08%
Net income growth years	2
OCF growth	-32.26%
Revenue growth	-4.55%
Revenue growth (Q)	-18.66%
Revenue growth (QoQ)	-17.53%
Revenue growth 10Y	11.13%
Revenue growth 3Y	8.38%
Revenue growth 5Y	13.07%
Revenue growth years	2

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	CAD -642,822
Depreciation and amortization	CAD 949,121
EBIT	CAD -1.4M
EBITDA	CAD -477,964
EPS	CAD -0.02
FCF per share	CAD 0.00
Financing cash flow	CAD -533,884
Free cash flow	CAD 254,369
Free cash flow minus SBC	CAD 121,651
Gross profit	CAD 15.4M
Investing cash flow	CAD -673,377
Net borrowing	CAD -533,043
Net cash flow	CAD -310,070
Net income	CAD -1.7M
Operating cash flow minus SBC	CAD 764,473
Operating income	CAD -1.4M
Revenue	CAD 24.9M
Stock-based compensation	CAD 132,718

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-0.86
Book value per share	CAD 0.05
Debt / EBITDA	113.41
Debt / equity	1.23
Debt / FCF	19.45
Interest coverage	-6.52
Long-term assets	CAD 3.4M
Long-term liabilities	CAD 4.5M
Net cash (debt)	CAD -4.4M
Net cash / market cap	-47.31%
Net debt / equity	1.1
Net debt / FCF	17.43
Piotroski F-Score	5
Property, plant and equipment	CAD 2.1M
Shareholders' equity	CAD 4M
Tangible book value	CAD 3.2M
Tangible book value per share	CAD 0.04
Total assets	CAD 12.7M
Total cash	CAD 514,977
Total debt	CAD 4.9M
Total liabilities	CAD 8.7M
WACC	2.03%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	1.71
Current assets	CAD 9.3M
Current liabilities	CAD 4.1M
Current ratio	2.25
Inventory turnover	1.88
Net working capital	CAD 5.1M
Quick ratio	1.02
Working capital	CAD 5.2M
Working capital turnover	6.17

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0.25%
Shareholder yield	-0.25%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-68.42%
10Y return CAGR	-10.89%
10Y total return	-68.42%
150-day SMA	CAD 0.23
1D price change	0%
1M price change	-11.11%
1M total return	-11.11%
1Y price change	-60.66%
1Y return CAGR	-60.68%
1Y total return	-60.66%
20-day SMA	CAD 0.14
200-day SMA	CAD 0.24
3M price change	-44.19%
3M total return	-44.19%
3Y price change	-68.42%
3Y return CAGR	-31.9%
3Y total return	-68.42%
50-day SMA	CAD 0.18
50-day SMA vs 200-day SMA	50under200
52-week high	CAD 0.33
52-week high date	2025-11-12
52-week low	CAD 0.12
52-week low date	2026-10-27
5Y price change	-60%
5Y return CAGR	-16.75%
5Y total return	-60%
6M price change	-56.36%
6M total return	-56.36%
All-time high	CAD 6.60
All-time high date	2014-01-17
All-time low	CAD 0.08
All-time low date	2017-12-28
Average true range (ATR)	CAD 0.01
Average volume	22.3K
Beta (1Y)	-0.64
Beta (2Y)	0.22
Beta (5Y)	-0.55
Change from 52-week high	-63.08%
Change from 52-week low	0%
Change from all-time high	-98.18%
Change from all-time low	50%
Monthly RSI	32.53
Previous close	CAD 0.12
Price vs 150-day SMA	-48.59%
Price vs 20-day SMA	-11.44%
Price vs 200-day SMA	-50.7%
Price vs 50-day SMA	-31.93%
Relative volume	5.9
RSI	37.58
Sharpe ratio	-0.95
Sharpe ratio (3Y)	-0.16
Sharpe ratio (5Y)	0.21
Sortino ratio	-1.19
Sortino ratio (3Y)	-0.16
Sortino ratio (5Y)	0.39
Volume	0
Weekly RSI	21.01
YTD price change	-55.56%
YTD total return	-55.56%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	58.9M
Shares change (QoQ)	0%
Shares change (YoY)	0.25%
Shares held by insiders	23.82%
Shares held by institutions	0.29%
Shares outstanding	78.1M

Deeper analysis on TSXV/ASG

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this TSXV/ASG report

Is a complete TSXV/ASG research report available?

No complete published report is available for tsxv/ASG (TSXV/ASG) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

TSXV/ASG (TSXV/ASG)

Price

Financial snapshot

Fair-value bridge

Latest news · TSXV/ASG

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TSXV/ASG indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on TSXV/ASG

Frequently asked questions